September 10, 2010

Press Releases

1325 Press Releases
DateTitleCompany
13 May 09 Novartis names Jonathan Symonds deputy CFO and CFO designate PharmiWeb
13 May 09 AstraZeneca Announces Top Line Results From Pivotal Phase III Study for BRILINTA PharmiWeb
13 May 09 ADDING MULTIMEDIA Greg Simon, Noted Leader In Health And Science Policy, Joins Pfizer
13 May 09 Putting The Patient In Control Next Stage In Personal Healthcare Budgets Announced PharmiWeb
12 May 09 Sanofi-aventis builds a New Vaccine Manufacturing Facility in France with an investment of 350 million euros PharmiWeb.com
12 May 09 Groundbreaking Diabetes Disease Management Program Honored With URAC National Best Practices Award Eli Lilly
11 May 09 HRA Pharma and Preglem announce successful completion of PHASE IIB for Ulipristal Acetate for the treatment of Uterine Fibroids Capital MSL
11 May 09 ICON Named a Favourite Contract Research Organisation by Pharmaceutical and Biotechnology Firms Weber Shandwick
11 May 09 AstraZeneca Announces Top Line Results From Pivotal Phase III Study for BRILINTA AstraZeneca
11 May 09 Outcome of new Mirapexin®/ Sifrol® (pramipexole) study set to change treatment of depressive symptoms in Parkinson`s disease Boehringer Ingelheim
11 May 09 HIV/AIDS Research Network Recommends Use of Abbott RealTime Viral Load Test for NIH-Sponsored Clinical Trials Abbott
11 May 09 Glivec® approved in EU as first post-surgery therapy to reduce risk of cancer returning in patients with aggressive gastrointestinal tumors Novartis
08 May 09 New study results further support the evidence that the HPV vaccine Gardasil® will provide long-lasting protection Sanofi Pasteur MSD
08 May 09 New data for GlaxoSmithKline’s vaccine, Cervarix®, presented at IPV Conference GlaxoSmithKline
08 May 09 Community healthcare charities receive £300,000 from GlaxoSmithKline in recognition of their work GlaxoSmithKline
08 May 09 DAIICHI SANKYO awarded the “Best Cardiovascular Pipeline” Distinction by „R&D Directions Magazine“ for the pharmaceutical company DAIICHI SANKYO
08 May 09 NICE Appraisal Consultation Document does not recommend funding Nexavar® (sorafenib) for advanced liver cancer patients Cohn & Wolfe
07 May 09 U.S. FDA Licenses Sanofi Pasteur’s New Influenza Vaccine Manufacturing Facility Sanofi Pasteur
07 May 09 Call for UK bioscience organisations to identify specialist skills that could be lost from the research community BBSRC Media Office
06 May 09 Important New Treatment Option Approved in US for Patients with the Most Aggressive Form of Brain Cancer Roche
06 May 09 Pfizer And Wisconsin Alumni Research Foundation (WARF) Sign License Agreement For Human Embryonic Stem Cells Pfizer
05 May 09 New Analyses from 16-Year Follow-up Trial with Betaseron® Demonstrated that Early and Sustained Treatment of Multiple Sclerosis Patients Enrolled in the Trial Affected Their Long-term Outcomes Bayer
05 May 09 Sanofi-aventis converts its Vitry-sur-Seine Industrial Facility to Biotechnologies Sanofi-aventis
05 May 09 Dr. Freda Lewis-Hall Joins Pfizer As Chief Medical Officer Pfizer
05 May 09 New study shows that Mirapexin®/Sifrol® (pramipexole) relieves depressive symptoms of Parkinson`s disease (PD), a common non-motor symptom affecting PD patients` quality of life Boehringer Ingelheim
05 May 09 NicOx co-presents four posters on PF¬03187207 for glaucoma at ARVO with Pfizer Inc Citigate
03 May 09 NHS Staff Receive £1.5 Million To Help Innovation In Community Services Department of Health
01 May 09 Prestigious European R&D Prize Won By Ark Founder Ark Therapeutics
30 Apr 09 PHARMIWEB SOLUTIONS SHORTLISTED FOR TWO MAJOR AWARDS PharmiWeb
29 Apr 09 Way Forward For The National Programme For IT

SIGN IN

Not got a Detail-Direct.com username and password?

Register Here.

Forgot Password?